“…Studies investigating fatigue in SARDs however, lack consistency, with investigators using various different tools to define fatigue, in markedly varied patient groups. 3 This has resulted in poor clinical management of fatigue in these patients, with patients often feeling dismissed by their physicians. 4 Though many studies have investigated fatigue in Rheumatoid arthritis (RA), 2 , 5 Systemic lupus erythematosus (SLE), 5 and systemic sclerosis (SSc), 1 much less has been documented about fatigue in primary systemic vasculitis (PSV), a concerning finding since the prevalence of fatigue in PSV is high (up to 91.2%).…”